(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione

C33H38N8O7S — CID 139598730

IUPAC(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione
SMILESCc1oc2nc1C(=O)N[C@@H](C(C)C)c1nc(cs1)C(=O)NCCN(C(=O)Cn1ccc(=O)[nH]c1=O)CCCC(=O)N[C@H]2Cc1ccccc1
InChIInChI=1S/C33H38N8O7S/c1-19(2)27-32-36-23(18-49-32)29(45)34-12-15-40(26(44)17-41-14-11-25(43)37-33(41)47)13-7-10-24(42)35-22(16-21-8-5-4-6-9-21)31-39-28(20(3)48-31)30(46)38-27/h4-6,8-9,11,14,18-19,22,27H,7,10,12-13,15-17H2,1-3H3,(H,34,45)(H,35,42)(H,38,46)(H,37,43,47)/t22-,27-/m0/s1
InChIKeyIZSQHFNRYZAVEZ-CUNXSJBXSA-N
MW690.78 g/mol
LogP1.87
Rot. Bonds5

About (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione

(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione (PubChem CID 139598730) has the molecular formula C33H38N8O7S and a molecular weight of 690.78 g/mol. Its IUPAC name is (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione.

Molecular Properties

Compound Name(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione
PubChem CID139598730
Molecular FormulaC33H38N8O7S
Molecular Weight690.78 g/mol
Exact Mass690.26
IUPAC Name(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione
SMILESCc1oc2nc1C(=O)N[C@@H](C(C)C)c1nc(cs1)C(=O)NCCN(C(=O)Cn1ccc(=O)[nH]c1=O)CCCC(=O)N[C@H]2Cc1ccccc1
InChIInChI=1S/C33H38N8O7S/c1-19(2)27-32-36-23(18-49-32)29(45)34-12-15-40(26(44)17-41-14-11-25(43)37-33(41)47)13-7-10-24(42)35-22(16-21-8-5-4-6-9-21)31-39-28(20(3)48-31)30(46)38-27/h4-6,8-9,11,14,18-19,22,27H,7,10,12-13,15-17H2,1-3H3,(H,34,45)(H,35,42)(H,38,46)(H,37,43,47)/t22-,27-/m0/s1
InChIKeyIZSQHFNRYZAVEZ-CUNXSJBXSA-N
XLogP1.87
TPSA201.39 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds5
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500690.78
LogP ≤ 51.87
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione?
The IUPAC name of (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione (CID 139598730) is (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione.
What is the SMILES notation for (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione?
The canonical SMILES for (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione is Cc1oc2nc1C(=O)N[C@@H](C(C)C)c1nc(cs1)C(=O)NCCN(C(=O)Cn1ccc(=O)[nH]c1=O)CCCC(=O)N[C@H]2Cc1ccccc1.
What is the InChIKey of (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione?
The InChIKey is IZSQHFNRYZAVEZ-CUNXSJBXSA-N. The full InChI is InChI=1S/C33H38N8O7S/c1-19(2)27-32-36-23(18-49-32)29(45)34-12-15-40(26(44)17-41-14-11-25(43)37-33(41)47)13-7-10-24(42)35-22(16-21-8-5-4-6-9-21)31-39-28(20(3)48-31)30(46)38-27/h4-6,8-9,11,14,18-19,22,27H,7,10,12-13,15-17H2,1-3H3,(H,34,45)(H,35,42)(H,38,46)(H,37,43,47)/t22-,27-/m0/s1.
What are the key properties of (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione?
(4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione has a molecular weight of 690.78 g/mol, XLogP of 1.87, 5 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,19S)-19-benzyl-13-[2-(2,4-dioxopyrimidin-1-yl)acetyl]-22-methyl-4-propan-2-yl-21-oxa-6-thia-3,10,13,18,23,24-hexazatricyclo[18.2.1.15,8]tetracosa-1(22),5(24),7,20(23)-tetraene-2,9,17-trione is sourced from PubChem (CID 139598730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).